TECHNOLOGY
SERVICES
PRODUCTS
NEWS + EVENTS
JOBS
 |
Welcome to TaconicArtemis |
 |
Hudson and Cologne, May 2, 2007ARTEMIS and Taconic Acquire Chemical Genetics Technology From CGI Pharmaceuticals, Inc. more...
Cologne, 22. March 2007ARTEMIS Announces Publication on a Novel RNAi-based Approach for Inducible and Reversible Gene Knockdown in Transgenic Micemore...
Cologne, 29. January 2007ARTEMIS Pharmaceuticals, CLEA Japan, Inc. and In-Vivo Science, Inc. Form Strategic Alliance for Generation and Marketing of Genetically Engineered Mouse Models.more...
|
|||||||||||||||||||||
|
|||||||||||||||||||||
From Gene Function To New And Better Medicines
TaconicArtemis GmbH, based in Cologne, Germany was founded in 1998 and has made significant advances to provide rapid, efficient and sophisticated techniques for the analysis of gene function in vertebrates.
Our activities are dedicated towards the provision of transgenic mouse generation services, tools and related licenses to the industrial and academic community. We operate on a fee for service basis and have a wide range of collaboration possibilities to provide solutions for our customers. Customers include Merck and Co. Inc., Bayer Schering Pharma, Sanofi-Aventis, Biovitrum, EVOTEC Neurosciences, Regeneron Pharmaceuticals, Boehringer Ingelheim and a large number of other companies and universities.
To find out how we can help you, please visit our Products and Services section. TaconicArtemis cooperates with leading Pharmaceutical and Biotech Companies and Academic Institutions around the world.
| TaconicArtemis in the News ARTEMIS is referred to in FINANCIAL TIMES DEUTSCHLAND on 2007 Nobel Price. |
Our customers TaconicArtemis selected customers. |
